Latest Safety News

Clarity Pharmaceuticals reports robust progress in prostate cancer and neuroendocrine tumour trials alongside a strong cash position of $226.2 million, underpinning its path towards commercialisation.

Bathurst Resources reported a first-half FY26 EBITDA of NZD 16 million, maintaining its full-year guidance despite export challenges and cost pressures. Key development projects in New Zealand and Canada continue to advance steadily.

Actinogen Medical has completed enrolment for its pivotal XanaMIA Alzheimer's trial ahead of schedule, with a positive interim analysis supporting continuation. The company is gearing up for an open-label extension and advancing commercial and partnership strategies.

Andromeda Metals has made significant strides in advancing its Great White and High Purity Alumina projects, underpinned by a $14 million capital raise and the commencement of Early Works at the Great White site.

Actinogen Medical’s pivotal XanaMIA trial for Alzheimer’s disease has received a green light from its independent Data Monitoring Committee to continue, reinforcing confidence in the drug’s safety and efficacy profile.

Kaiser Reef Limited reported a robust December quarter with nearly 7,000 ounces of gold produced at Henty, a 29% increase in gold reserves, and a strengthened cash position of A$43.1 million.

Tolu Minerals Limited reports steady progress at its Tolukuma Gold Mine, advancing a major mine expansion project targeting 500 tonnes per day production by the first quarter of 2027. Key infrastructure developments, drilling expansion, and processing plant refurbishments underpin the company’s growth strategy.

Kingsgate Consolidated has delivered a stellar December quarter, boosting cash reserves by 56% and maintaining robust production guidance for FY26 amid favourable gold and silver prices.

Peninsula Energy reports strong progress at its Lance Uranium Project in Wyoming, with key production milestones reached and the company on track to meet 2026 uranium output targets amid a buoyant market.

OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.

Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.

TerraCom Limited reported a stable operational quarter despite logistical challenges impacting coal shipments and cash flow, while successfully raising A$60 million to bolster liquidity. The Blair Athol mine life was extended to 2033, underpinning the company’s long-term outlook.